Showing latest transactions and SEC Form 4 filings for AQST.
7 results.
| X | Filing Date | Trade Date | Ticker | Company Name | Insider Name | Title | Trade Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 16:00:08 | 2026-11-12 | AQST | Aquestive Therapeutics, Inc. | Davis Matthew W. | Chief Development Officer | S - Sale | $3.55 | -7,197 | 87,500 | -8% | -$25,526 | |
| M | 2026-11-12 11:59:24 | 2026-11-10 | AQST | Aquestive Therapeutics, Inc. | Daly Richard J | Director | P - Purchase | $3.54 | +28,025 | 29,225 | +1,118% | +$99,331 |
| 2026-11-12 11:17:21 | 2026-11-10 | AQST | Aquestive Therapeutics, Inc. | Davis Matthew W. | Chief Development Officer | OTHER | $3.52 | +5,303 | 94,697 | 0% | +$18,667 | |
| D | 2026-11-10 10:42:45 | 2026-11-06 | AQST | Aquestive Therapeutics, Inc. | Daly Richard J | Director | A | $0.00 | +57,000 | 0 | 0% | $0 |
| 2026-10-23 13:38:54 | 2026-10-21 | AQST | Aquestive Therapeutics, Inc. | Cochran John | Director | OTHER | $0.00 | +62,229 | 161,715 | 0% | $0 | |
| 2026-10-16 14:17:30 | 2026-10-15 | AQST | Aquestive Therapeutics, Inc. | Barber Daniel | President and CEO, Director | S - Sale | $4.22 | -25,000 | 627,317 | -4% | -$105,600 |